TY - JOUR
KW - Adult
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Cross-Sectional Studies
KW - Female
KW - Humans
KW - Male
KW - Medication Adherence/psychology
KW - Middle Aged
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/drug therapy
KW - Outpatients
KW - Patient Dropouts
KW - Retrospective Studies
KW - Treatment Outcome
KW - United States
AU - S. R. Noe
AU - T. Keller
A1 - 
AB - Opiate addiction is a serious global health issue that profoundly impacts the welfare of populations around the world. Opioid addiction affects an estimated 1.9 million individuals in the United States alone, stimulating a rise in treatment options such as medication-assisted treatment with buprenorphine. When combined with counseling and relapse prevention groups, medication-assisted treatment has proven to be an effective office-based opioid treatment for opiate dependence. Office-based opioid treatment has broadened access to treatment of opioid dependence, has decreased the risk for overdose, and is effective for reducing cravings and opioid use at proper dosing levels. However, treatment retention and relapse remain significant challenges. The purpose of this study was to identify characteristics predictive of retention in treatment time of opioid-dependent individuals receiving office-based buprenorphine treatment. The records of individuals enrolled in a public health office buprenorphine clinic (n = 350) were analyzed to determine retention time in treatment and whether retention time varied by selected individual variables. Participants in the study had a cumulative predicted retention time on buprenorphine of 65% at 30 days, 35% at 6 months, 25% at 12 months, and 18% at 18 months.
AD - Shelly R. Noe, DNP, PMHNP-BC, New Mexico State University, Las Cruces, New Mexico and Teresa Keller, PhD, RN, New Mexico State University, Las Cruces, New Mexico.
BT - Journal of addictions nursing
C5 - Education & Workforce; Opioids & Substance Use
CP - 1
CY - United States
DO - 10.1097/JAN.0000000000000320
IS - 1
JF - Journal of addictions nursing
LA - eng
M1 - Journal Article
N2 - Opiate addiction is a serious global health issue that profoundly impacts the welfare of populations around the world. Opioid addiction affects an estimated 1.9 million individuals in the United States alone, stimulating a rise in treatment options such as medication-assisted treatment with buprenorphine. When combined with counseling and relapse prevention groups, medication-assisted treatment has proven to be an effective office-based opioid treatment for opiate dependence. Office-based opioid treatment has broadened access to treatment of opioid dependence, has decreased the risk for overdose, and is effective for reducing cravings and opioid use at proper dosing levels. However, treatment retention and relapse remain significant challenges. The purpose of this study was to identify characteristics predictive of retention in treatment time of opioid-dependent individuals receiving office-based buprenorphine treatment. The records of individuals enrolled in a public health office buprenorphine clinic (n = 350) were analyzed to determine retention time in treatment and whether retention time varied by selected individual variables. Participants in the study had a cumulative predicted retention time on buprenorphine of 65% at 30 days, 35% at 6 months, 25% at 12 months, and 18% at 18 months.
PP - United States
PY - 2020
SN - 1548-7148; 1088-4602
SP - 23
EP - 29
EP - 
T1 - Office-Based Buprenorphine Treatment: Identifying Factors That Promote Retention in Opioid-Dependent Patients
T2 - Journal of addictions nursing
TI - Office-Based Buprenorphine Treatment: Identifying Factors That Promote Retention in Opioid-Dependent Patients
U1 - Education & Workforce; Opioids & Substance Use
U2 - 32132421
U3 - 10.1097/JAN.0000000000000320
VL - 31
VO - 1548-7148; 1088-4602
Y1 - 2020
Y2 - Jan/Mar
ER -